Your browser doesn't support javascript.
loading
Guidelines to improve animal study design and reproducibility for Alzheimer's disease and related dementias: For funders and researchers.
Snyder, Heather M; Shineman, Diana W; Friedman, Lauren G; Hendrix, James A; Khachaturian, Ara; Le Guillou, Ian; Pickett, James; Refolo, Lorenzo; Sancho, Rosa M; Ridley, Simon H.
Afiliación
  • Snyder HM; Division of Medical & Scientific Relations, Alzheimer's Association, Chicago, IL, USA. Electronic address: hsnyder@alz.org.
  • Shineman DW; Scientific Affairs, Alzheimer's Drug Discovery Foundation, New York, NY, USA.
  • Friedman LG; Scientific Affairs, Alzheimer's Drug Discovery Foundation, New York, NY, USA.
  • Hendrix JA; Division of Medical & Scientific Relations, Alzheimer's Association, Chicago, IL, USA.
  • Khachaturian A; Editorial Office, Alzheimer's & Dementia: The Journal of the Alzheimer's Association, Washington, DC, USA.
  • Le Guillou I; Research Division, Alzheimer's Society, London, UK.
  • Pickett J; Research Division, Alzheimer's Society, London, UK.
  • Refolo L; Division of Neuroscience, National Institute on Aging at the National Institutes of Health, Bethesda, MD, USA.
  • Sancho RM; Research Division, Alzheimer's Research UK, Cambridge, UK.
  • Ridley SH; Research Division, Alzheimer's Research UK, Cambridge, UK.
Alzheimers Dement ; 12(11): 1177-1185, 2016 11.
Article en En | MEDLINE | ID: mdl-27836053
ABSTRACT
The reproducibility of laboratory experiments is fundamental to the scientific process. There have been increasing reports regarding challenges in reproducing and translating preclinical experiments in animal models. In Alzheimer's disease and related dementias, there have been similar reports and growing interest from funding organizations, researchers, and the broader scientific community to set parameters around experimental design, statistical power, and reporting requirements. A number of efforts in recent years have attempted to develop standard guidelines; however, these have not yet been widely implemented by researchers or by funding agencies. A workgroup of the International Alzheimer's disease Research Funder Consortium, a group of over 30 research funding agencies from around the world, worked to compile the best practices identified in these prior efforts for preclinical biomedical research. This article represents a consensus of this work group's review and includes recommendations for researchers and funding agencies on designing, performing, reviewing, and funding preclinical research studies.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proyectos de Investigación / Demencia / Modelos Animales de Enfermedad Tipo de estudio: Guideline / Prognostic_studies Límite: Animals Idioma: En Revista: Alzheimers Dement Año: 2016 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proyectos de Investigación / Demencia / Modelos Animales de Enfermedad Tipo de estudio: Guideline / Prognostic_studies Límite: Animals Idioma: En Revista: Alzheimers Dement Año: 2016 Tipo del documento: Article